

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh


IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh


(Sharecast News) - Silence Therapeutics announced a collaboration with Hansoh Pharmaceutical Group on Friday, to develop short interfering ribonucleic...


(Sharecast News) - Silence Therapeutics announced the appointment of John Strafford to the newly-created role of senior vice-president of business dev...


IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca


(Sharecast News) - Silence Therapeutics reported revenues from collaborations of £5.8m in its first half on Thursday, up from £1.1m year-on-...


UK earnings, trading statements calendar - next 7 days


EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO